Loading clinical trials...
Loading clinical trials...
A Phase II Study of Bendamustine Plus Rituximab (BR) in Patients With Relapsed or Progressive Marginal Zone B-cell Lymphoma (MZBCL)
Conditions
Interventions
bendamustine plus rituximab
Locations
11
South Korea
Chonbuk National University Hospital
Jeonju, Jeollabuk-do, South Korea
Hallym University Medical Center
Anyang-si, South Korea
Chungnam National University
Daejeon, South Korea
Gachon University Gil Medical Center
Incheon, South Korea
Gyeongsang National University Hospital
Jinju, South Korea
Seoul National University Bundang Hospital
Seongnam, South Korea
Start Date
May 1, 2015
Primary Completion Date
October 1, 2019
Completion Date
October 1, 2019
Last Updated
September 24, 2021
NCT03314974
NCT01815749
NCT01769222
NCT01523223
NCT01261247
NCT00536601
Lead Sponsor
Seoul National University Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions